Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

GT Biopharma (GTBP) Short Interest Ratio & Short Volume

GT Biopharma logo
$0.43 +0.01 (+3.27%)
Closing price 05/21/2026 04:00 PM Eastern
Extended Trading
$0.44 +0.00 (+0.46%)
As of 05/21/2026 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

GT Biopharma Short Interest Overview

As of April 30, 2026, GT Biopharma (GTBP) had a short interest of 604,557 shares sold short, representing 1.76% of the public float. This marks a -9.91% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.9, meaning it would take 0.9 days of the average trading volume of 1.94 million shares to cover all short positions.

Current Short Interest
604,557 shares
Previous Short Interest
671,073 shares
Change Vs. Previous Month
-9.91%
Dollar Volume Sold Short
$186.32 thousand
Short Interest Ratio
0.9 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
36,060,000 shares
Short Percent of Float
1.76%
Today's Trading Volume
938,770 shares
Average Trading Volume
1,942,434 shares
Today's Volume Vs. Average
48%
Short Selling GT Biopharma?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for GT Biopharma and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

GTBP Short Interest Over Time

GTBP Days to Cover Over Time

GTBP Percentage of Float Shorted Over Time

GT Biopharma Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2026604,557 shares $186.32 thousand -9.9%1.8%0.88 $0.31
4/15/2026671,073 shares $260.38 thousand -10.2%2.2%1.27 $0.39
3/31/2026747,375 shares $305.00 thousand -26.7%2.5%1.14 $0.41
3/13/20261,019,371 shares $422.53 thousand -51.2%3.3%1.4 $0.41
2/27/20262,089,377 shares $998.72 thousand -20.5%20.3%2.26 $0.48
2/13/20262,629,402 shares $1.22 million -2.3%25.6%1.4 $0.46
1/30/20262,691,277 shares $1.78 million +11.0%26.2%3.37 $0.66
1/15/20262,425,158 shares $1.77 million +14.9%23.6%1.18 $0.73
12/31/20252,111,313 shares $1.66 million +45.3%20.6%0.79 $0.79
12/15/20251,453,242 shares $911.33 thousand -11.2%14.1%1.34 $0.63
11/28/20251,636,186 shares $1.28 million +14.6%15.9%2 $0.78
11/14/20251,427,430 shares $1.31 million +8.9%13.9%0.82 $0.92
10/31/20251,310,410 shares $821.89 thousand +25.4%38.1%2.25 $0.63
10/15/20251,040,000 shares $762.84 thousand +325.7%33.6%0.6 $0.73
9/30/2025244,300 shares $143.28 thousand -18.4%7.9%0.2 $0.59
9/15/2025299,500 shares $239.72 thousand +63.7%9.7%1.4 $0.80
8/31/2025183,000 shares $171.01 thousand -29.9%6.0%1 $0.93
8/15/2025261,000 shares $349.74 thousand -7.6%8.6%2.8 $1.34
7/31/2025282,300 shares $525.08 thousand +3.2%10.5%3.1 $1.86
7/15/2025273,500 shares $547 thousand -11.4%10.2%3.3 $2.00
6/30/2025308,700 shares $1.11 million +40.3%11.5%4.2 $3.58
6/15/2025220,100 shares $625.08 thousand +45.0%8.5%4.2 $2.84
5/31/2025151,800 shares $390.13 thousand +315.9%7.4%3.2 $2.57
5/15/202536,500 shares $81.76 thousand -5.7%1.8%0.1 $2.24
4/30/202538,700 shares $93.65 thousand -23.5%1.7%0.1 $2.42
4/15/202550,600 shares $119.92 thousand -30.0%2.3%0.1 $2.37
3/31/202572,300 shares $155.45 thousand -23.3%3.2%0.1 $2.15
3/15/202594,200 shares $241.15 thousand -62.4%4.2%0.1 $2.56
2/28/2025250,300 shares $595.71 thousand +35.8%11.2%0.3 $2.38
2/15/2025184,300 shares $394.40 thousand -6.2%9.4%0.2 $2.14
1/31/2025196,500 shares $438.20 thousand +5.1%10.0%0.5 $2.23
1/15/2025186,900 shares $439.22 thousand +107.7%9.5%0.4 $2.35
12/31/202490,000 shares $274.50 thousand +556.9%4.6%0.2 $3.05
12/15/202413,700 shares $37.68 thousand +23.4%0.7%0 $2.75
11/30/202411,100 shares $31.08 thousand -42.8%0.6%0.5 $2.80
11/15/202419,400 shares $56.65 thousand +9.6%1.0%1 $2.92
10/31/202417,700 shares $52.04 thousand +70.2%0.9%1.1 $2.94
10/15/202410,400 shares $20.70 thousand +108.0%0.5%0.7 $1.99
9/30/20245,000 shares $11.55 thousand -35.9%0.2%0.4 $2.31
9/15/20247,800 shares $17.00 thousand -16.1%0.4%0.3 $2.18
I had never heard of this 1888 account (Ad)

An investment account dating back to 1888 has quietly delivered average annual returns of 29% over the last 25 years - and BlackRock, JP Morgan, and Bank of America have all used it. Most ordinary investors have never heard of it. It is not a stock, not crypto, and not a typical retirement product. A free presentation explains exactly what it is and how regular investors may access it with just a few hundred dollars.tc pixel

Watch the free presentation to learn how this account works
8/31/20249,300 shares $20.00 thousand -51.8%0.4%0.3 $2.15
8/15/202419,300 shares $44.39 thousand +14.9%0.9%0.5 $2.30
7/31/202416,800 shares $43.85 thousand +1.8%0.8%0 $2.61
7/15/202416,500 shares $46.70 thousand -61.6%0.8%0 $2.83
6/30/202443,000 shares $121.69 thousand +34.4%2.1%0 $2.83
6/15/202432,000 shares $92.48 thousand -11.1%1.6%0 $2.89
5/31/202436,000 shares $135 thousand +1,233.3%1.8%0 $3.75
5/15/20242,700 shares $8.24 thousand -55.0%0.2%0 $3.05
4/30/20246,000 shares $18 thousand +81.8%0.5%0.5 $3.00
4/15/20243,300 shares $12.41 thousand -62.5%0.3%0.3 $3.76
3/31/20248,800 shares $38.98 thousand +79.6%0.7%0.7 $4.43
3/15/20244,900 shares $22.69 thousand -14.0%0.4%0.4 $4.63
2/29/20245,700 shares $24.28 thousand +72.7%0.5%0.6 $4.26
2/15/20243,300 shares $13.20 thousand +312.5%0.3%0.4 $4.00
1/31/2024800 shares $4.75 thousand -98.6%0.1%0.1 $5.94
1/15/202458,800 shares $13.17 thousand +150.2%0.2%0.4 $0.22
12/31/202323,500 shares $5.99 thousand -64.8%0.1%0.2 $0.26
12/15/202366,800 shares $16.47 thousand +14.8%0.2%0.6 $0.25
11/30/202358,200 shares $12.80 thousand -62.3%0.2%0.5 $0.22
11/15/2023154,300 shares $37.03 thousand +16.1%0.4%1.2 $0.24
10/31/2023132,900 shares $33.28 thousand -16.8%0.4%0.9 $0.25
10/15/2023159,800 shares $40.75 thousand +56.4%0.4%1 $0.26
9/30/2023102,200 shares $24.64 thousand +122.2%0.3%0.4 $0.24
9/15/202346,000 shares $12.88 thousand -12.9%0.1%0.1 $0.28
8/31/202352,800 shares $13.78 thousand -76.7%0.1%0.1 $0.26
8/15/2023227,000 shares $60.00 thousand +22.3%0.6%0.4 $0.26
7/31/2023185,600 shares $51.04 thousand -15.6%0.5%0.3 $0.28
7/15/2023219,900 shares $73.40 thousand -1.7%0.6%0.4 $0.33
6/30/2023223,600 shares $69.76 thousand +9.3%0.6%0.4 $0.31
6/15/2023204,600 shares $71.59 thousand +53.5%0.6%0.5 $0.35
5/31/2023133,300 shares $30.02 thousand -5.7%0.4%0.5 $0.23
5/15/2023141,400 shares $42.39 thousand -12.8%0.4%0.9 $0.30

GTBP Short Interest - Frequently Asked Questions

Short interest is the volume of GT Biopharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 604,557 shares of GTBP short. 1.76% of GT Biopharma's shares are currently sold short. Learn More on GT Biopharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GTBP shares currently have a short interest ratio of 0.9. Learn More on GT Biopharma's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.76% of GT Biopharma's floating shares are currently sold short.

GT Biopharma saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 604,557 shares, a decline of 9.9% from the previous total of 671,073 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

1.76% of GT Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to GT Biopharma: Elutia Inc. (0.41%), Incannex Healthcare Inc. (8.43%), InterCure Ltd. (0.06%), Atossa Genetics Inc. (4.35%), Lite Strategy, Inc. (0.27%), Synaptogenix, Inc. (8.63%), Talphera, Inc. (2.08%), MIRA Pharmaceuticals, Inc. (1.05%), Telomir Pharmaceuticals, Inc. (2.98%), Alterity Therapeutics Limited - Sponsored ADR (0.26%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling GTBP is an investing strategy that aims to generate trading profit from GT Biopharma as its price is falling. GTBP shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for GT Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GTBP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GTBP, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like GTBP:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:GTBP) was last updated on 5/22/2026 by MarketBeat.com Staff.
From Our Partners
System failure: The strongest leverage for gold…
$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...
Golden Portfolio | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
I had never heard of this 1888 account
An investment account dating back to 1888 has quietly delivered average annual returns of 29% over the last 25...
The Oxford Club | Sponsoredtc pixel
"Computers are about to become obsolete" - George Gilder. Here’s why.
George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...
Eagle Publishing | Sponsoredtc pixel
SpaceX controls two-thirds of all satellites - and it is about to go public
SpaceX is targeting an IPO on June 11th, with trading set to begin June 12th and the roadshow kicking off June...
NXT Wave Research | Sponsoredtc pixel
How to Profit from Elon’s AI lab before it goes public
Elon Musk's AI lab has partnered with the Department of Defense, Oracle, and Palantir - and he just filed conf...
InvestorPlace | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel